Welcome to our dedicated page for Dentsply Sirona news (Ticker: XRAY), a resource for investors and traders seeking the latest updates and insights on Dentsply Sirona stock.
DENTSPLY SIRONA Inc. (Nasdaq: XRAY) regularly issues news and updates that shed light on its role as the world’s largest diversified manufacturer of professional dental products and technologies. Company press releases cover topics such as strategic partnerships, leadership changes, financial results and portfolio decisions, giving investors and dental professionals insight into how the business is evolving.
Recent news has highlighted Dentsply Sirona’s focus on connected dentistry and technology-enabled solutions. The company has announced expanded and renewed distribution partnerships in the United States that provide access to its dental technology portfolio, including systems and imaging solutions referenced in those agreements. These announcements emphasize integrated ecosystems that connect devices, software and services from scanning through design and manufacturing workflows.
News items also address corporate strategy and performance, including quarterly financial results and the introduction of a Return-to-Growth action plan. In these updates, Dentsply Sirona outlines priorities such as putting customers at the center, strengthening the U.S. business, and evolving operations to support innovation and training. Leadership appointments in commercial, finance and regional roles are frequently reported, reflecting the company’s efforts to align its organization with these priorities.
Other press releases describe decisions about the Wellspect Healthcare business, dividend declarations, participation in investor conferences and the conclusion of an SEC Division of Enforcement investigation without enforcement action. Together, these news items provide a detailed view of how Dentsply Sirona manages its portfolio, governance and capital allocation. Readers interested in XRAY can use this news feed to follow developments in connected dentistry, strategic partnerships, governance actions and financial communications from the company.
Dentsply Sirona (Nasdaq: XRAY) announced a ruling on June 23, 2020, by the U.S. District Court for New Mexico, confirming that EdgeTaper Encore endodontic files infringe on three valid patents owned by Dentsply Sirona. The court also dismissed a request from Edge to dismiss claims of willful infringement, which could lead to treble damages. A trial is scheduled to begin on August 17, 2020, to address Dentsply Sirona's claims for willful infringement and damages related to additional patent claims.
Dentsply Sirona, a leading Dental Solutions Company, will attend the Stifel 2020 Jaws and Paws Conference on May 27, 2020. CEO Don Casey is set to participate in a fireside chat at 4:45 PM ET. Investors can access a live audio webcast of the presentation at www.dentsplysirona.com, with a replay available later. With a legacy of 132 years, Dentsply Sirona is the world's largest manufacturer of dental products, offering innovative solutions to enhance patient care. The company's stock is traded on Nasdaq under the symbol XRAY.
Dentsply Sirona (Nasdaq: XRAY) reported preliminary financial results for Q1 2020, with net sales of $874.3 million, a 7.6% decline year-over-year. The operating loss was $124.8 million, impacted by a $156.6 million non-cash goodwill impairment. Non-GAAP EPS stood at $0.43, down 12.2% from the previous year. The company has ~$1.3 billion in available liquidity. Due to COVID-19 uncertainties, guidance for fiscal year 2020 was withdrawn. Management noted early signs of demand recovery as markets begin to reopen.
Summary not available.